Evidence map›Paper›PMID 42261759›Full record

ArticleBJPsych open2026

The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trials.

Helena Werin Sjögren, Evana López, Alexander Lisinski, Mikael Landén, Johan Lundberg, Fredrik Hieronymus

Abstract read
In one paragraph

Article in BJPsych open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Helena Werin SjögrenDepartment of Pharmacology, https://ror.org/01tm6cn81Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.
Evana LópezDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Alexander LisinskiDepartment of Pharmacology, https://ror.org/01tm6cn81Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-3130-0172
Mikael LandénDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.
Johan LundbergDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Fredrik HieronymusDepartment of Pharmacology, https://ror.org/01tm6cn81Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-0930-6068

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe primary effect parameter in depression trials is usually a measure of depressive symptoms, e.g. the Hamilton Depression Rating Scale (HDRS). Such measures have been criticised for not covering patient-relevant domains, such as quality of life, and hence not accurately reflecting patient-experienced efficacy.

aimsTo investigate the relation between clinician-rated depressive symptoms and patient-reported quality of life measured by the Quality-of-Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF).

methodWe included data from six acute-phase trials (

resultsQ-LES-Q-SF ratings correlated strongly with HDRS-17 (

conclusionsHDRS and Q-LES-Q-SF showed considerable agreement in depressed study participants treated with antidepressants, suggesting that HDRS meaningfully reflects patient-reported improvement.

Indexed as

antidepressantsclinical outcomes measuresDepressive disordersmeta-analysisquality of life

Identifiers

PMID42261759
PMCPMC13276756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.